These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 19956849)
1. The assessment of methylated BASP1 and SRD5A2 levels in the detection of early hepatocellular carcinoma. Tsunedomi R; Ogawa Y; Iizuka N; Sakamoto K; Tamesa T; Moribe T; Oka M Int J Oncol; 2010 Jan; 36(1):205-12. PubMed ID: 19956849 [TBL] [Abstract][Full Text] [Related]
2. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search. Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357 [TBL] [Abstract][Full Text] [Related]
3. Quantitative methylation analysis of multiple genes using methylation-sensitive restriction enzyme-based quantitative PCR for the detection of hepatocellular carcinoma. Hua D; Hu Y; Wu YY; Cheng ZH; Yu J; Du X; Huang ZH Exp Mol Pathol; 2011 Aug; 91(1):455-60. PubMed ID: 21600201 [TBL] [Abstract][Full Text] [Related]
4. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038 [TBL] [Abstract][Full Text] [Related]
5. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma. Zhang C; Li Z; Cheng Y; Jia F; Li R; Wu M; Li K; Wei L Clin Cancer Res; 2007 Feb; 13(3):944-52. PubMed ID: 17289889 [TBL] [Abstract][Full Text] [Related]
6. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma. Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857 [TBL] [Abstract][Full Text] [Related]
7. 5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC. Qiu G; Fang J; He Y Clin Biochem; 2006 Mar; 39(3):259-66. PubMed ID: 16516880 [TBL] [Abstract][Full Text] [Related]
8. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma. Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608 [TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma. Huang ZH; Hu Y; Hua D; Wu YY; Song MX; Cheng ZH Exp Mol Pathol; 2011 Dec; 91(3):702-7. PubMed ID: 21884695 [TBL] [Abstract][Full Text] [Related]
10. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas. Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125 [TBL] [Abstract][Full Text] [Related]
11. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas. Gao W; Kondo Y; Shen L; Shimizu Y; Sano T; Yamao K; Natsume A; Goto Y; Ito M; Murakami H; Osada H; Zhang J; Issa JP; Sekido Y Carcinogenesis; 2008 Oct; 29(10):1901-10. PubMed ID: 18632756 [TBL] [Abstract][Full Text] [Related]
12. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Furuta M; Kozaki KI; Tanaka S; Arii S; Imoto I; Inazawa J Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643 [TBL] [Abstract][Full Text] [Related]
13. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390 [TBL] [Abstract][Full Text] [Related]
14. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma]. Liu WJ; Wang L; Wang JP; Li JQ; Zhang CQ; Zheng L; Yuan YF Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763 [TBL] [Abstract][Full Text] [Related]
15. [Screening for differential methylation status by CpG island microarray in the hepatocellular carcinoma cell lines]. Zheng D; Liu BB; Liu YK; Kang XN; Sun L; Guo K; Sun RX; Chen J; Zhao Y Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):891-6. PubMed ID: 19173987 [TBL] [Abstract][Full Text] [Related]
16. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Schagdarsurengin U; Wilkens L; Steinemann D; Flemming P; Kreipe HH; Pfeifer GP; Schlegelberger B; Dammann R Oncogene; 2003 Mar; 22(12):1866-71. PubMed ID: 12660822 [TBL] [Abstract][Full Text] [Related]
17. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Iwata N; Yamamoto H; Sasaki S; Itoh F; Suzuki H; Kikuchi T; Kaneto H; Iku S; Ozeki I; Karino Y; Satoh T; Toyota J; Satoh M; Endo T; Imai K Oncogene; 2000 Nov; 19(46):5298-302. PubMed ID: 11077447 [TBL] [Abstract][Full Text] [Related]
18. Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis. Yu J; Zhang HY; Ma ZZ; Lu W; Wang YF; Zhu JD Cell Res; 2003 Oct; 13(5):319-33. PubMed ID: 14672555 [TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma. Lv Z; Zhang M; Bi J; Xu F; Hu S; Wen J Am J Clin Pathol; 2006 May; 125(5):740-6. PubMed ID: 16707376 [TBL] [Abstract][Full Text] [Related]
20. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma. Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]